Use of treatment pathway improves neoadjuvant chemotherapy use in muscle-invasive bladder cancer.

Kassem S FarajAnojan K NavaratnamSarah EversmanLaila EliasAmit SyalMark D TysonErik P Castle

Published in: International urology and nephrology (2021)

In this review of 20 years of experience, we report a dramatic rise in the use of NAC after adoption of a multidisciplinary pathway that is associated with expected survival benefits.

Keyphrases

neoadjuvant chemotherapy
muscle invasive bladder cancer
locally advanced
lymph node
sentinel lymph node
transcription factor
squamous cell carcinoma
rectal cancer
quality improvement
radiation therapy
free survival